Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

New BMS drug trumps peg-interferon alpha

April 4, 2011 Research and Development, Sales and Marketing BMS, EASL, hepatitis C, pegintron alfa

Bristol-Myers Squibb has been given a boost by trial results which suggest its compound for hepatitis C, PEG-Interferon lambda, is …
News

Angela Pasma to lead Chiltern’s new Netherlands office

April 1, 2011 Research and Development appointment, chiltern, research and development

Contract research organisation Chiltern has expanded its European operations, opening a new office in the Netherlands. The Leiden office will …
Appointment
Amgen

Amgen’s novel lung cancer drug disappoints in phase III

April 1, 2011 Research and Development Amgen, Millennium, NSCLC, Takeda, motesanib, non-small cell lung cancer

Amgen’s lung cancer drug motesanib has not meet its primary endpoint in a phase III study. The drug, developed in …
News
GlaxoSmitKline

GSK details $28.5m of research payments to US institutions

April 1, 2011 Research and Development GSK, payments

GlaxoSmithKline has made public the payments it gave last year to US institutions engaged in clinical research on its behalf. …
News

TcL Pharma appoints French pharma veterans

April 1, 2011 Research and Development, Sales and Marketing TcL, appointment, biotech, recruitment

TcL Pharma has appointed two seasoned veterans of the French pharmaceutical industry. Dr Jean-Hugues Masgnaux joins the French biotech company …
News
Cephalon

Valeant makes $5.7 billion hostile bid for Cephalon

March 31, 2011 Research and Development, Sales and Marketing Cephalon, Valeant

Valeant has made a hostile bid for Cephalon, but analysts believe its offer is too low for the deal to …
News

Roche appoints Janet Hammond to translational medicine role

March 31, 2011 Research and Development appointment, research and development

Janet Hammond has joined Roche to drive the early clinical development strategy for its virology discovery and translational area. She …
Appointment

EU Clinical Trials Register is Launched

March 29, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates

The European Medicines Agency (EMA) has announced the launch of its EU Clinical Trials Register. This online register allows public …
News
Press release

Chiltern Expands European Operations with a New Office in The Netherlands

March 29, 2011 Research and Development

Chiltern International Limited (Chiltern), a global clinical contract research organization (CRO) announced that it has opened a new office in …
News
Press release

Telaprevir to be added to standard hep C therapy

March 27, 2011 Research and Development, Sales and Marketing hepatitis C, telaprevir

Telaprevir – currently being co-developed by Vertex, Johnson & Johnson and Mitsubishi Tanabe  – will become part of a standard …
News

GSK withdraws applications for Avodart

March 25, 2011 Research and Development Avodart, Cancer, GSK, bph, prostate cancer

GlaxoSmithKline has withdrawn all regulatory applications for Avodart to prevent prostate cancer after regulators raised doubts about its benefit/risk profile. …
News
Sanofi-Aventis headquarters

Sanofi signs ophthalmology research collaboration

March 25, 2011 Research and Development Fovea, Sanofi-Aventis, Vision Institute, ophthalmology

Sanofi-Aventis has penned a collaboration with one of the main eye disease research centres in Europe. The three-year agreement between …
News

Cephalon buys Gemin X for $225 million

March 24, 2011 Research and Development Cephalon, lung cancer

Cephalon is to acquire oncology specialist Gemin X and gain access to its cancer candidate obatoclax. The US biopharmaceutical firm …
News
aquapharm_bertrand_lehuu

Bertrand Lehuu joins Aquapharm

March 24, 2011 Research and Development appointment, research and development

Scottish marine biotechnology company Aquapharm Biodiscovery has appointed Bertrand Lehuu as senior VP – pharma business. Bertrand has almost 30 …
Appointment

Budget provides UK science incentives

March 24, 2011 Research and Development George Osborne, R&D tax credits, clinical trials

Chancellor George Osborne has unveiled tax incentives, new funding and moves to cut red tape for the life sciences sector …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026